Episode 1: Sending the Immune System Back to School Against Cancer
Dr. Steven O'Day of Agenus speaks with Dr. Alexander (Lex) Eggermont, one of Europe's leading immunotherapy experts. They set the stage for a potentially transformative new generation of cancer care.
The Immuno-Oncology Curve with Dr. Steven O'Day
A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus.
A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus.Listen on
Substack App
RSS Feed
Appears in episode
Dr. Steven O'Day
